Aimee S Payne MD PhD

Professor and Chair, Dermatology, Columbia University

Education & Training

University of Pennsylvania Health SystemResidency, Dermatology, 2002 - 2005
Pennsylvania Hospital of the University of Pennsylvania Health SystemInternship, Internal Medicine, 2001 - 2002
Washington University in St. Louis School of MedicineClass of 2001
Stanford UniversityBS, Biology, 1989 - 1993

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

NIH Dermatology Funding Rides the Post-Pandemic Economic Rollercoaster.
Andrew M Overmiller, Aimee S Payne
The Journal of Investigative Dermatology. 2025-10-01
1 citations
Pemphigus Vulgaris Autoantibodies Induce an Endoplasmic Reticulum Stress Response.
Coryn L Hoffman, Navaneetha Krishnan Bharathan, Yoshitaka Shibata, William Giang, Johann E Gudjonsson
The Journal of Investigative Dermatology. 2025-09-01
Immunoregulatory effects of TPM203 peptide-nanoparticle therapy in pemphigus vulgaris.
Chuda Rujitharanawong, Aimee S Payne
The British Journal of Dermatology. 2025-08-21

Lectures

Optimized FVIII-Domain-Based Chimeric Antigen Receptors to Specifically Target FVIII Inhibitor-Producing B Cells in Hemophilia a
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Cutaneous complications of conventional chemotherapy agents
Payne AS, Savarese DM
http://www.uptodate.com/contents/cutaneous-complications-of-conventional-chemotherapy-agents
UpToDate, Wolters Kluwer Health - 2013-01-23
Cutaneous complications of molecularly targeted therapy and other biologic agents used for cancer therapy
Payne AS, Savarese DM
http://www.uptodate.com/contents/cutaneous-complications-of-molecularly-targeted-therapy-and-other-b
UpToDate, Wolters Kluwer Health - 2013-02-14
Chemotherapy-induced alopecia
Payne AS
http://www.uptodate.com/contents/chemotherapy-induced-alopecia
UpToDate, Wolters Kluwer Health - 2013-02-12
Extravasation injury from chemotherapy and other non-neoplastic vesicants
Payne AS, Savarese DM
http://www.uptodate.com/contents/extravasation-injury-from-chemotherapy-and-other-non-neoplastic-ves
UpToDate, Wolters Kluwer Health - 2012-12-18
Join now to see all

Know Thyself: Can CAR T Therapies Transform Treatment of Autoimmune Diseases?February 11th, 2025
Phase 1 Trial of MuSK-CAART Therapy Is RecruitingJanuary 26th, 2023
Penn Medicine Researchers Working on Personalized, CAR T-like Treatment for Rare Form of Autoimmune Disease Myasthenia GravisJanuary 25th, 2023
Join now to see all

Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgarisCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2028
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgarisCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2028
Role Of Autoantibody Isotype In Pemphigus PathogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
Tissue And Keratinocyte ProcurementNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2011
Cloning And Characterization Of Human Pemphigus AutoantibodiesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2011

Aetna Choice POS II
Aetna HMO
AmeriHealth Direct POS
Amerihealth HMO
AmeriHealth PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
First Health PPO
Great West PPO
HealthAmerica HealthAssurance PPO
Horizon BCBS Direct Access
Horizon BCBS HMO
Horizon BCBS POS
Horizon BCBS PPO
Humana ChoiceCare Network PPO
IBC Keystone HMO / POS
IBC Personal Choice PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment